A Phase 2 Trial Testing ZP1848 in Patients With SBS

See also
Status	Clinical Trial	Phase
Enrolling by invitation	`NCT05635747` - A 90 Day Observational Study as an Extension to the Phase 3,Open Labeled Exploratory Study of RELiZORB
Completed	`NCT01891279` - Elemental Formula in Neonates Post Small Bowel Resection: Improved Weaning From Total Parenteral Nutrition?	N/A
Completed	`NCT00930644` - Open-Label Study of Teduglutide for Subjects With PN-Dependent Short Bowel Syndrome (SBS)	Phase 3
Completed	`NCT01696656` - Prescription Pattern of Adjuvant Drugs and Vitamins in Patients Undergoing Long-term Home Nutritional Support for Intestinal Insufficiency	N/A
Completed	`NCT00910104` - Cholestasis Reversal: Efficacy of IV Fish Oil	Phase 2/Phase 3
Completed	`NCT04981262` - Improved Quality of Life in Children With Intestinal Failure	N/A
Completed	`NCT01930539` - Treatment of Vitamin D Deficiency in Intestinal Rehabilitation Clinic Patients With a Portable Ultraviolet B Lamp	N/A
Recruiting	`NCT05023382` - A Study of Teduglutide in Japanese People With Short Bowel Syndrome
Recruiting	`NCT04733066` - Quality of Life in Patients With Short Bowel Syndrome Treated Without and With Teduglutide - a Prospective Nested Matched Pair Analysis
Terminated	`NCT00742157` - Evaluate the Efficacy and Safety Growth Hormone, Glutamine and Diet in Patients With Short Bowel Syndrome (SBS)	Phase 4
Completed	`NCT04743960` - Assessing Metabolic and Sleep Consequences of Overnight Home Parenteral Nutrition	N/A
Completed	`NCT03690206` - Efficacy And Safety Evaluation of Glepaglutide in Treatment of Short Bowel Syndrome (SBS)	Phase 3
Terminated	`NCT02266849` - Loperamide vs. Placebo's Effect on Ileostomy Output: A Clinical Randomized Blinded Cross-over Study	Phase 3
Completed	`NCT01306838` - Early Provision of Enteral Microlipid and Fish Oil to Infants With Enterostomy	Early Phase 1
Completed	`NCT01380366` - rHGH and Intestinal Permeability in Intestinal Failure	Phase 4
Completed	`NCT00248573` - Mechanisms of Adaptation in Human Short Bowel Syndrome	Phase 1/Phase 2
Withdrawn	`NCT03371862` - Liraglutide on Decreasing Parenteral Support in Short Bowel Patients (SLIPS)	Phase 2
Completed	`NCT04474743` - Malnutrition in Chronic Gastrointestinal Diseases, Cross-sectional Study
Completed	`NCT00067860` - Diet/Growth Factor Mechanisms of Gut Adaptation	Phase 2
Terminated	`NCT04046328` - Efficacy, Safety and Tolerability of Enteric-Coated Cholestyramine Capsules for Adult Short Bowel Syndrome	Phase 2

NCT number	NCT02690025
Study type	Interventional
Source	Zealand Pharma
Contact
Status	Completed
Phase	Phase 2
Start date	February 2016
Completion date	May 2017

A Phase 2 Trial Testing ZP1848 in Patients With SBS — glepaglutide

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms